Buy Dr Reddys Labs, target of Rs 581: Angel
Angel Broking has maintained its buy rating on Dr Reddys Laboratories (DRL) with a target of Rs 581. For 2QFY2009, DRL registered 26.2% yoy growth in Net Sales to Rs 1,576 crore (Rs 1,249 crore) primarily aided by growth in the North American market.
